1224590

Molecular PharmaGroup LLC — FEI 3014413265

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 11, 2023
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
New Providence, NJ (United States)

Citations

IDCFRDescription
22779FDCA 503B(b)(2)(A)All inclusive product report, not submitted
22787FDCA 503B(a)(10)(A)Drug product labels, fails to include